Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag Long-term Safety Extension in China
CTR20202101Phase 4Completed
- Sponsor
- GSK
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of eltrombopag in immune thrombocytopenic purpura (ITP), Thrombocytopenia, sponsored by GSK. Started Nov 2020; status: completed.
02
Drugs
eltrombopag
03
Conditions
immune thrombocytopenic purpura (ITP)Thrombocytopenia
Beyond the preview
Go deeper on CTR20202101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202101.